NO20042257L - Fremgangsmate for behandling av depresjon med deltareseptoragonistforbindelser - Google Patents

Fremgangsmate for behandling av depresjon med deltareseptoragonistforbindelser

Info

Publication number
NO20042257L
NO20042257L NO20042257A NO20042257A NO20042257L NO 20042257 L NO20042257 L NO 20042257L NO 20042257 A NO20042257 A NO 20042257A NO 20042257 A NO20042257 A NO 20042257A NO 20042257 L NO20042257 L NO 20042257L
Authority
NO
Norway
Prior art keywords
receptor agonist
treating depression
agonist compounds
delta receptor
delta
Prior art date
Application number
NO20042257A
Other languages
English (en)
Norwegian (no)
Inventor
William Pendergast
Kwen-Jen Chang
Peter J Gengo
Original Assignee
Ardent Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ardent Pharmaceuticals Inc filed Critical Ardent Pharmaceuticals Inc
Publication of NO20042257L publication Critical patent/NO20042257L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20042257A 2001-10-29 2004-06-01 Fremgangsmate for behandling av depresjon med deltareseptoragonistforbindelser NO20042257L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34008401P 2001-10-29 2001-10-29
US33788701P 2001-11-02 2001-11-02
PCT/US2002/034421 WO2003037342A1 (en) 2001-10-29 2002-10-29 Method of treating depression with delta receptor agonist compounds

Publications (1)

Publication Number Publication Date
NO20042257L true NO20042257L (no) 2004-06-24

Family

ID=26990913

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20042257A NO20042257L (no) 2001-10-29 2004-06-01 Fremgangsmate for behandling av depresjon med deltareseptoragonistforbindelser

Country Status (11)

Country Link
US (1) US7030124B2 (cg-RX-API-DMAC7.html)
EP (1) EP1450807B1 (cg-RX-API-DMAC7.html)
JP (1) JP4892654B2 (cg-RX-API-DMAC7.html)
CN (1) CN1596113B (cg-RX-API-DMAC7.html)
CA (1) CA2464471C (cg-RX-API-DMAC7.html)
MX (1) MXPA04004059A (cg-RX-API-DMAC7.html)
NO (1) NO20042257L (cg-RX-API-DMAC7.html)
PL (1) PL371297A1 (cg-RX-API-DMAC7.html)
RU (1) RU2314809C2 (cg-RX-API-DMAC7.html)
TW (1) TW200300089A (cg-RX-API-DMAC7.html)
WO (1) WO2003037342A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1269805C (zh) * 2001-05-18 2006-08-16 阿斯特拉曾尼卡有限公司 4－(苯基－哌嗪基－甲基)－苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用
US8476280B2 (en) * 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
SE0203300D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) * 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
US7314880B2 (en) * 2003-01-02 2008-01-01 Mount Cook Biosciences, Inc. Cardioprotective delta opioid receptor agonists and methods of using same
NZ593444A (en) 2003-10-01 2012-12-21 Adolor Corp 4-[(2-N,N-diethylaminocarbonyl)pyrid-5-yl]-spiro[1,2-dihydronaphthalene-2,4'-piperidine] and methods of its use
MX2007001240A (es) * 2004-08-02 2007-03-23 Astrazeneca Ab Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas.
SE0401968D0 (sv) * 2004-08-02 2004-08-02 Astrazeneca Ab Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7683168B2 (en) * 2005-04-14 2010-03-23 Mount Cook Bio Sciences, Inc. Compositions of novel opioid compounds and method of use thereof
TW200803856A (en) 2005-09-02 2008-01-16 Mount Cook Biosciences Inc Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
NZ590041A (en) * 2008-05-20 2012-11-30 Astrazeneca Ab Method of treating anxious major depressive disorder
CN103467460A (zh) * 2013-09-23 2013-12-25 昆明理工大学 一类含噻吩环和苄基的二芳基甲基哌嗪化合物及其应用
CN105646151B (zh) * 2016-02-26 2018-06-29 山西大学 一种炔类化合物及其制备方法和该化合物的用途
WO2017173067A1 (en) 2016-03-31 2017-10-05 Versi Group, Llc Delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinson's disease

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
US5807858A (en) * 1996-06-05 1998-09-15 Delta Pharmaceutical, Inc. Compositions and methods for reducing respiratory depression
US5681830A (en) * 1992-02-03 1997-10-28 Delta Pharmaceuticals, Inc. Opioid compounds
US5574159A (en) * 1992-02-03 1996-11-12 Delta Pharmaceuticals, Inc. Opioid compounds and methods for making therefor
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
US5985880A (en) * 1996-06-05 1999-11-16 Delta Pharmaceuticals Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds
US20020052007A1 (en) * 1992-02-03 2002-05-02 Chang Kwen Jen Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives
AU692788B2 (en) * 1993-07-30 1998-06-18 Ardent Pharmaceuticals, Inc. Piperazine compounds used in therapy
US6046200A (en) * 1994-09-09 2000-04-04 The United States Of America As Represented By The Secretary Of The Army Compositions having neuroprotective and analgesic activity
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
GB9709972D0 (en) * 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
GB9804734D0 (en) * 1998-03-05 1998-04-29 Pfizer Ltd Compounds
ATE273970T1 (de) * 1998-04-16 2004-09-15 Pfizer Prod Inc N-acyl und n-aroyl aralkylamide
SE9904673D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904674D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904675D0 (sv) * 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
GB0017256D0 (en) * 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
CN1269805C (zh) 2001-05-18 2006-08-16 阿斯特拉曾尼卡有限公司 4－(苯基－哌嗪基－甲基)－苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用

Also Published As

Publication number Publication date
WO2003037342A1 (en) 2003-05-08
CN1596113B (zh) 2010-05-26
TW200300089A (en) 2003-05-16
US7030124B2 (en) 2006-04-18
CA2464471C (en) 2012-05-15
MXPA04004059A (es) 2005-03-31
EP1450807B1 (en) 2013-12-25
CN1596113A (zh) 2005-03-16
US20030144299A1 (en) 2003-07-31
CA2464471A1 (en) 2003-05-08
RU2314809C2 (ru) 2008-01-20
EP1450807A4 (en) 2008-06-25
JP2005508363A (ja) 2005-03-31
EP1450807A1 (en) 2004-09-01
RU2004115748A (ru) 2005-03-27
JP4892654B2 (ja) 2012-03-07
PL371297A1 (en) 2005-06-13

Similar Documents

Publication Publication Date Title
NO20042257L (no) Fremgangsmate for behandling av depresjon med deltareseptoragonistforbindelser
NO20011121D0 (no) FremgangsmÕte for formasjonsbehandling med deformerbare partikler
PL367272A1 (en) Novel substituted benzimidazole dosage forms and method of using same
DK1488180T3 (da) Fremgangsmåde til tørring af vandige fluider med højt lactoseindhold
HUP0303624A3 (en) N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad and process for preparation of the compounds
DK1383733T3 (da) Fremgangsmåde til fremstilling af 1,3-substituerede indener og aryl-sammenföjede azapolycykliske forbindelser
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
FI20012271L (fi) Menetelmä vastinpisteiden määrittämiseksi
IL146598A0 (en) Method for the preparation of aggregates
EE05247B1 (et) Meetod imidasoolhendite valmistamiseks
FI20030022L (fi) Menetelmä ja laitteisto optoelektronisen puolijohdekomponentin lämpötilan säätämiseksi
NO20052262D0 (no) Fremgangsmate til fremstilling av 4-substituerte 2,2,6,6-tetrametyl-piperidin-N-oksy- og 2,2,6,6-tetrametyl-piperidin-N-hydroksy-forbindelser
AU2002361357A8 (en) Method for monosulphonylation of an aminobenzofuran compound
AU2003214800A1 (en) Method of treating sexual dysfunctions with delta opioid receptor agonist compounds
NO20014222L (no) Fremgangsmåte for behandling av COPD
FI20021390A7 (fi) Menetelmä pinnan ominaisuuksien säätämiseksi
EE05381B1 (et) MeetodÁ2-(asendatudÁfenl)-2-hdroksetlkarbamaatideÁvalmistamiseks,ÁselleksÁvajalikudÁvahehendidÁningÁsaadudÁkarbamaatideÁpolmorfsedÁvormid
NO20033356D0 (no) Fremgangsmåte for fremstilling av DTPA-monoamider
DK1451177T3 (da) Substituerede 2-pyrrolidin-2-yl-1H-indol-derivater til behandling af migræne
AU2002366272A8 (en) Edg-receptor agonist for the treatment of hypertension
NO20012863D0 (no) Metode for registrering av overheng
NO20034513L (no) Fremgangsmåte for ihibering av adhesjonsdannelse
PL352959A1 (en) Method of obtaining derivatives of taxane
NO20052950L (no) Ny fremgangsmate for fremstilling av imidazolforbindelser
NO20015625L (no) Fremgangsmåte for reduksjon av NOx

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application